Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2003
07/10/2003US20030129170 Central nervous system disorders; antidiabetic agents
07/10/2003US20030129169 Novel expression vectors and uses thereof
07/10/2003US20030129168 Expression of proteins for treating asthma via ligand mediated activation of their encoding genes
07/10/2003US20030129164 Expression of glial-derived neurotrophic factor for treatment of diseases of the eye
07/10/2003US20030129163 Retroviral vectors including modified envelope escort proteins
07/10/2003US20030129091 Medical diagnosis; reducing stresses on sperm; artificial insemination
07/10/2003CA2506538A1 Bacterial superantigen vaccines
07/10/2003CA2473788A1 New tumour markers and biological applications thereof
07/10/2003CA2472123A1 Proteins of non typable haemophilus influenzae
07/10/2003CA2471924A1 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death
07/10/2003CA2471920A1 Improved structured-functional bonding matrices for biomolecules
07/10/2003CA2471916A1 Modified bacterial surface layer proteins
07/10/2003CA2471667A1 Nucleotide sequences having activity of controlling translation efficiency and utilization thereof
07/10/2003CA2471333A1 Modified tetracycline repressor protein compositions and methods of use
07/10/2003CA2471306A1 Secreted proteins
07/10/2003CA2471297A1 Human netrin receptor and uses thereof
07/10/2003CA2471130A1 Il-17 like molecules and uses thereof
07/10/2003CA2471127A1 An antisense strategy to modulate estrogen receptor response (er.alpha. and/or er.beta.)
07/10/2003CA2471119A1 Lipase genes and proteins
07/10/2003CA2471109A1 Enzymatic redox labelling of nucleic acids
07/10/2003CA2471042A1 Expression vectors and promoters for heterologous gene expression
07/10/2003CA2471035A1 Knockout swine and methods for making the same
07/10/2003CA2470903A1 A system for stable expression of sirnas in mammalian cells
07/10/2003CA2470781A1 Cystine-knot fold protein
07/10/2003CA2470707A1 Cellular compositions and methods of making and using them
07/10/2003CA2470666A1 Secreted protein
07/10/2003CA2469690A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003CA2469012A1 Process of producing glutamate derivatives
07/10/2003CA2468619A1 Adiponectin fragments and conjugates
07/10/2003CA2468081A1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
07/10/2003CA2463143A1 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
07/10/2003CA2462768A1 Self-assembling polymers, and materials fabricated therefrom
07/10/2003CA2458751A1 Compositions and methods for the treatement of immune related diseases
07/09/2003EP1325960A2 Negative strand RNA virus vector having autonomously replicating activity
07/09/2003EP1325959A1 Transformation system of fungus belonging to the genus monascus
07/09/2003EP1325958A1 Genetic sequence coding for creatinine deiminase, and its use
07/09/2003EP1325957A2 Recombinant papilloma virus L1
07/09/2003EP1325956A1 Plant lesion formation suppressing gene, sp17 and use theriof
07/09/2003EP1325955A1 Compounds and methods for the identification and/or validation of a target
07/09/2003EP1325954A1 An inhibitor of arthropod chitin synthase
07/09/2003EP1325932A2 Anti-vegf antibodies
07/09/2003EP1325931A1 Inhibitors of human neutrophil elastase
07/09/2003EP1325930A1 Mammal prolactin variants
07/09/2003EP1325929A2 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants
07/09/2003EP1325776A1 Semiconductor device for detecting organic molecules and method for measuring organic molecules using the same
07/09/2003EP1325678A1 Animal showing schizophrenia-like abnormality in cognitive behaviors and method of constructing the same
07/09/2003EP1325459A1 High throughput processing system and method of using
07/09/2003EP1325341A2 Modulation of ligand binding/enzymatic activity of alpha beta proteins
07/09/2003EP1325338A2 Diagnosis and treatment of alzheimer's disease
07/09/2003EP1325336A2 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein
07/09/2003EP1325154A2 Method for the detection of cytosine methylations
07/09/2003EP1325153A2 Genetic determinants for dermal inflammation and immunity
07/09/2003EP1325152A2 Method for detecting pre-disposition to hepatotoxicity
07/09/2003EP1325151A2 Improved binding interactions in dipstick assays
07/09/2003EP1325150A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain
07/09/2003EP1325149A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart
07/09/2003EP1325145A1 Adenoviral vectors for gene delivery in skeletal muscle cells or myoblasts
07/09/2003EP1325144A2 Chromosomal vectors and uses thereof
07/09/2003EP1325143A1 Method for generating or increasing resistance to biotic or abiotic stress factors in organisms
07/09/2003EP1325142A2 Virus-based amplification vectors for plants
07/09/2003EP1325141A1 Whisker-mediated transformation of embryogenic cotton suspension cultures
07/09/2003EP1325140A2 A nitrate-responsive plant root specific transcriptional factor
07/09/2003EP1325139A1 Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals
07/09/2003EP1325138A2 Optimized messenger rna
07/09/2003EP1325137A2 Truncated phosphodiesterase-7 polypeptides
07/09/2003EP1325136A1 Herbicide resistant plants
07/09/2003EP1325134A2 Method to alter sugar moieties
07/09/2003EP1325133A2 Bvh-a2 and bvh-a3 antigens of group b streptococcus
07/09/2003EP1325132A2 Human ion channel protein and polynucleotides encoding the same
07/09/2003EP1325131A2 A human-protein coupled receptor, hgprbmy6, expressed highly in small intestine
07/09/2003EP1325130A2 Nogo receptor homologs
07/09/2003EP1325129A2 Identification of a new cytotoxic activity from the ink of aplysia punctata
07/09/2003EP1325128A2 Lipocalins
07/09/2003EP1325126A2 Human ion-exchanger proteins and polynucleotides encoding the same
07/09/2003EP1325125A2 Chromosome 3p21.3 genes are tumor suppressors
07/09/2003EP1325124A2 Clk-2, cex-7 and coq-4 genes, and uses thereof
07/09/2003EP1325123A1 Inhibition of stenosis or restenosis by p-selectin antagonists
07/09/2003EP1325122A2 Modulation of the transcription of pro-inflammatory gene products
07/09/2003EP1325121A2 Antisense oligonucleotide directed toward mammalian vegf receptor genes and uses thereof
07/09/2003EP1325119A2 Concatenated nucleic acid sequences
07/09/2003EP1325118A2 Oligonucleotide linkers comprising a variable cohesive portion and method for the preparation of polynucleotide libraries by using said linkers.
07/09/2003EP1325117A2 Lipid metabolism enzymes
07/09/2003EP1325116A2 Isoprenoid-dependent ras anchorage (idra) proteins
07/09/2003EP1325115A2 Cytokine receptor zcytor17
07/09/2003EP1325114A2 A human beta-ketoacyl synthase (46619) and uses thereof
07/09/2003EP1325108A1 Method and device for creating micro-arrays
07/09/2003EP1325033A2 Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection
07/09/2003EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof
07/09/2003EP1325031A2 Use of anti-human integrin alpha d antibodies to treat spinal cord injury
07/09/2003EP1325030A2 Genes isolated from dendritic cells, gene products and methods employing the same
07/09/2003EP1325029A2 Secreted proteins and their uses
07/09/2003EP1325027A2 Casein peptide fragments with growth-influencing activity on cell cultures
07/09/2003EP1325025A1 Peptide-based gemini surfactant compounds facilitating the transfer into cells
07/09/2003EP1325023A1 Method for modifying a protein structure
07/09/2003EP1325019A1 Antisense modulation of clusterin expression
07/09/2003EP1325018A1 Antisense modulation of her-2 expression
07/09/2003EP1324780A2 Cardiac arrhythmia treatment methods
07/09/2003EP1324778A2 Compositions and methods for the transport of biologically active agents across cellular barriers
07/09/2003EP1324768A2 Vaccines for proliferative ileitis
07/09/2003EP1324766A2 Methods and compositions for the treatment of peripheral artery disease
1 ... 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 ... 4023